- Home
- VERO vs PTIX Comparison
VERO vs PTIX Comparison
Compare VERO & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- PTIX
- Stock Information
- Founded
- VERO N/A
- PTIX 1994
- Country
- VERO Canada
- PTIX United States
- Employees
- VERO N/A
- PTIX N/A
- Industry
- VERO Medical/Dental Instruments
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- VERO Health Care
- PTIX Health Care
- Exchange
- VERO Nasdaq
- PTIX Nasdaq
- Market Cap
- VERO 2.4M
- PTIX 2.0M
- IPO Year
- VERO N/A
- PTIX 2016
- Fundamental
- Price
- VERO $2.26
- PTIX $0.23
- Analyst Decision
- VERO
- PTIX
- Analyst Count
- VERO 0
- PTIX 0
- Target Price
- VERO N/A
- PTIX N/A
- AVG Volume (30 Days)
- VERO 68.1K
- PTIX 324.0K
- Earning Date
- VERO 03-31-2025
- PTIX 05-14-2025
- Dividend Yield
- VERO N/A
- PTIX N/A
- EPS Growth
- VERO N/A
- PTIX N/A
- EPS
- VERO N/A
- PTIX N/A
- Revenue
- VERO $64,833,000.00
- PTIX N/A
- Revenue This Year
- VERO N/A
- PTIX N/A
- Revenue Next Year
- VERO $4.95
- PTIX N/A
- P/E Ratio
- VERO N/A
- PTIX N/A
- Revenue Growth
- VERO N/A
- PTIX N/A
- 52 Week Low
- VERO $2.20
- PTIX $0.18
- 52 Week High
- VERO $17.49
- PTIX $1.87
- Technical
- Relative Strength Index (RSI)
- VERO 38.89
- PTIX 42.29
- Support Level
- VERO $2.46
- PTIX $0.18
- Resistance Level
- VERO $4.03
- PTIX $0.28
- Average True Range (ATR)
- VERO 0.46
- PTIX 0.03
- MACD
- VERO -0.03
- PTIX -0.00
- Stochastic Oscillator
- VERO 3.28
- PTIX 44.44
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.